EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study

Menglan Zhai, Jianping Bi, Zirui Ke, Min Hu, Guoliang Pi, Ying Li, Hanping He, Yanping Li, Hongmei Zheng, Xinhong Wu, Vivek Verma, Jun Shao und 1 weitere

Breast Cancer: Targets and Therapy · 2026-03 · Volume 18 · 1-10

DOI: 10.2147/bctt.s577469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-03. Verfasst von Menglan Zhai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People'…. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

breast cancerimmunotherapyneoadjuvant therapypathological complete responsestereotactic body radiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, National Key Clinical Specialty, Wuhan, Hubei, People's Republic of China.
  • Wuhan Clinical Research Center for Breast Cancer, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan, Hubei, People's Republic of China.
  • Department of Pathology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

ORCID-Profile: Guang Han

Zitieren

APA

Zhai, M., Bi, J., Ke, Z., Hu, M., Pi, G., Li, Y., He, H., Li, Y., Zheng, H., Wu, X., Verma, V., Shao, J., & Han, G. (2026). Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study. Breast Cancer: Targets and Therapy, Volume 18, 1-10. https://doi.org/10.2147/bctt.s577469

Vancouver

Zhai M, Bi J, Ke Z, Hu M, Pi G, Li Y, et al. Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-10. doi:10.2147/bctt.s577469

BibTeX
@article{Zhai2026,
  author = {Zhai, Menglan and Bi, Jianping and Ke, Zirui and Hu, Min and Pi, Guoliang and Li, Ying and He, Hanping and Li, Yanping and Zheng, Hongmei and Wu, Xinhong and Verma, Vivek and Shao, Jun and Han, Guang},
  title = {Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--10},
  doi = {10.2147/bctt.s577469}
}
Kostenlos starten →